Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Iraqi women with PCOS often have higher testosterone levels and obesity.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Young women with PCOS and no other heart risk factors have normal heart function.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

A new low-cost method can accurately detect PCOS early by measuring free testosterone levels.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.